Fiona Bisshop

534 total citations
17 papers, 327 citations indexed

About

Fiona Bisshop is a scholar working on Infectious Diseases, Virology and Social Psychology. According to data from OpenAlex, Fiona Bisshop has authored 17 papers receiving a total of 327 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 7 papers in Virology and 5 papers in Social Psychology. Recurrent topics in Fiona Bisshop's work include HIV Research and Treatment (7 papers), HIV/AIDS drug development and treatment (6 papers) and LGBTQ Health, Identity, and Policy (5 papers). Fiona Bisshop is often cited by papers focused on HIV Research and Treatment (7 papers), HIV/AIDS drug development and treatment (6 papers) and LGBTQ Health, Identity, and Policy (5 papers). Fiona Bisshop collaborates with scholars based in Australia, France and Spain. Fiona Bisshop's co-authors include Joaquín Portilla, Kimberly Y. Smith, Brian Wynne, Christoph Wyen, Keith A. Pappa, Jonathan Wright, Jean van Wyk, Mounir Ait‐Khaled, Stéphane De Wit and Michael Aboud and has published in prestigious journals such as Clinical Infectious Diseases, JAIDS Journal of Acquired Immune Deficiency Syndromes and Immunology and Cell Biology.

In The Last Decade

Fiona Bisshop

14 papers receiving 324 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fiona Bisshop Australia 7 259 193 92 48 40 17 327
Sushma Kumar United States 9 284 1.1× 202 1.0× 80 0.9× 92 1.9× 25 0.6× 13 311
Rima Acosta United States 11 474 1.8× 343 1.8× 243 2.6× 60 1.3× 35 0.9× 17 512
Philippe Castiel France 6 277 1.1× 316 1.6× 64 0.7× 74 1.5× 15 0.4× 7 389
Laura Bracciale Italy 13 387 1.5× 414 2.1× 188 2.0× 154 3.2× 45 1.1× 21 584
Luminita Schneider France 12 231 0.9× 259 1.3× 92 1.0× 125 2.6× 19 0.5× 20 355
Gianmaria Baldin Italy 13 387 1.5× 294 1.5× 124 1.3× 84 1.8× 20 0.5× 50 457
Cal Cohen United States 8 219 0.8× 158 0.8× 91 1.0× 34 0.7× 10 0.3× 15 260
Kristen Andreatta United States 13 626 2.4× 493 2.6× 217 2.4× 80 1.7× 83 2.1× 33 651
Juan Tiraboschi Spain 13 312 1.2× 244 1.3× 108 1.2× 81 1.7× 27 0.7× 51 382
Isabelle Cohen-Codar France 13 355 1.4× 312 1.6× 107 1.2× 37 0.8× 19 0.5× 15 390

Countries citing papers authored by Fiona Bisshop

Since Specialization
Citations

This map shows the geographic impact of Fiona Bisshop's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fiona Bisshop with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fiona Bisshop more than expected).

Fields of papers citing papers by Fiona Bisshop

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fiona Bisshop. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fiona Bisshop. The network helps show where Fiona Bisshop may publish in the future.

Co-authorship network of co-authors of Fiona Bisshop

This figure shows the co-authorship network connecting the top 25 collaborators of Fiona Bisshop. A scholar is included among the top collaborators of Fiona Bisshop based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fiona Bisshop. Fiona Bisshop is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Fowler, James A., et al.. (2024). How low can you go? Titrating the lowest effective dose of cyproterone acetate for transgender and gender diverse people who request feminizing hormones. International Journal of Transgender Health. 26(4). 1046–1055. 6 indexed citations
3.
Wit, Stéphane De, Fabrice Bonnet, Olayemi Osiyemi, et al.. (2024). Durable Efficacy of Switching From a 3- or 4-Drug Tenofovir Alafenamide–Based Regimen to the 2-Drug Regimen Dolutegravir/Lamivudine in the TANGO Study Through Week 196. JAIDS Journal of Acquired Immune Deficiency Syndromes. 96(2). 156–160. 3 indexed citations
4.
Katlama, Christine, Fiona Bisshop, Johannes R. Bogner, et al.. (2024). Efficacy and safety of dolutegravir/lamivudine in virologically suppressed female participants: week 48 data from the pooled TANGO and SALSA studies. HIV Medicine. 25(7). 873–884.
5.
Fowler, James A., et al.. (2023). Highs, Lows, and Hormones: A Qualitative Metasynthesis of Transgender Individuals’ Experiences Undergoing Gender-Affirming Hormone Therapy. Journal of Homosexuality. 71(7). 1652–1683. 9 indexed citations
6.
7.
Dunn, Matthew, Scott Griffiths, Mark Bloch, et al.. (2023). Impact of harm reduction practice on the use of non-prescribed performance and image-enhancing drugs (PIEDs): The PUSH! Audit. Australian Journal of General Practice. 52(4). 197–202. 9 indexed citations
8.
Dunn, Matthew, Kevin Lee, Scott Griffiths, et al.. (2023). Monitoring and reporting of adverse effects of testosterone prescribing for gender affirmation at general practice clinics - Data from the PUSH! Audit. International Journal of Transgender Health. 25(4). 770–777. 2 indexed citations
9.
10.
Wyk, Jean van, F. Ajana, Fiona Bisshop, et al.. (2021). Switching to dolutegravir/lamivudine (DTG/3TC) fixed-dose combination (FDC) is non-inferior to continuing a tenofovir alafenamide (TAF)-based regimen (TBR) in maintaining virological suppression through 96 weeks (TANGO study). HIV Medicine. 22. 28–28.
11.
Osiyemi, Olayemi, Faïza Ajana, Fiona Bisshop, et al.. (2021). 900. Switching to DTG/3TC Fixed-Dose Combination (FDC) Is Non-inferior to Continuing a TAF-Based Regimen (TBR) in Maintaining Virologic Suppression Through 144 Weeks (TANGO Study). Open Forum Infectious Diseases. 8(Supplement_1). S541–S541. 7 indexed citations
12.
13.
Wyk, Jean van, F. Ajana, Fiona Bisshop, et al.. (2020). Switching to DTG/3TC fixed-dose combination (FDC) Is non-inferior to continuing a TAF-based regimen in maintaining virologic suppression through 48 weeks (TANGO Study). Journal of Infection and Public Health. 13(2). 349–349. 6 indexed citations
14.
Smith, Don, Ian Woolley, Darren Russell, Fiona Bisshop, & Virginia Furner. (2020). Trends in practice: attitudes and challenges in the diagnosis, treatment and management of HIV infection in Australia. Internal Medicine Journal. 50(S5). 5–17. 5 indexed citations
15.
Woolley, Ian, et al.. (2018). HIV in practice: current approaches and challenges in the diagnosis, treatment and management of HIV infection in Australia. HIV Medicine. 19(S3). 5–23. 10 indexed citations
16.
Sturm, Richard A., Fiona Bisshop, Hiromasa Takahashi, & Peter G. Parsons. (1991). A melanoma octamer binding protein is responsive to differentiating agents.. PubMed. 2(10). 519–24. 24 indexed citations
17.
Pope, JH, et al.. (1989). The value of MLA 144 culture fluid for the isolation of human immunodeficiency virus. Immunology and Cell Biology. 67(2). 147–149. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sushma Kumar Breakdown of academic impact, for papers by Rima Acosta Breakdown of academic impact, for papers by Philippe Castiel Breakdown of academic impact, for papers by Laura Bracciale Breakdown of academic impact, for papers by Luminita Schneider Breakdown of academic impact, for papers by Gianmaria Baldin Breakdown of academic impact, for papers by Cal Cohen Breakdown of academic impact, for papers by Kristen Andreatta Breakdown of academic impact, for papers by Juan Tiraboschi Breakdown of academic impact, for papers by Isabelle Cohen-Codar
Rankless by CCL
2026